Health and Healthcare
1079 Articles
The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the…
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the…
Caterpillar, UnitedHealth, Merck, and Verizon were among the largest losers among DJIA stocks on Thursday.
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
Apple, Disney, Merck, and Pfizer were the leading gainers among the Dow 30 stocks on Monday. Bitcoin settled up 23%…
The question for investors is pretty simple: 2017 was great, but what do they do for an encore in 2018?
Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic…
Microsoft and Vise were Wednesday's big DJIA gainers while Merck and Disney dipped the most.
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…
Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.
Intel, Merck, McDonald's, and Exxon Mobil weighed on the DJIA Friday.
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…
Our top personal finance-related articles today. Your wallet will thank you later.